Select Your Region

We noticed you visit this page from United States. Please select your preferred region to continue

skip to content

Country Selector

Based on your location

Europe

North America

Latin America

Asia-Pacific

Healthcare Professional Verification

This section contains medical information for licensed healthcare professionals only. Please confirm your professional status to continue.

Free Light Chains (FLC)

The next generation Free Light Chain Assay.

Published date: 3/8/2021 | Modified date: 6/9/2026

About FLC

  • Free Light Chains (FLCs) are immunoglobulin light chains which are circulating in serum in a free state (unbound). There are two types of immunoglobulin light chain produced in humans, designated kappa (κ) and lambda (λ).
  • The quantification of serum FLC is used as an aid in the diagnosis and monitoring patients with Multiple Myeloma.
  • Ratio FLC value (kappa FLC/lambda FLC) compared to reference ranges may indicate presence of plasma cell disorders disease like Multiple Myeloma or AL amyloidosis in a patient.
  • Nephelometric and turbidimetric based assays have been shown to overestimate the sFLC levels that are not always consistent with Serum Protein Electrophoresis/Immunofixation and other clinical parameters.

Key benefits

A trusted and cost-effective FLC solution with strong, proven performance, delivering highly reliable results essential across the entire the multiple myeloma patient journey.
  • Reliable and high analytical performance results

    with correct estimation of FLC values without antigen excess or overestimation by polymerization vs Nephelometry / Turbidimetry Methods.

  • Trust in the results

    with concordance value between SPE and FLC Kappa & FLC Lambda which help on interpretation results.

  • Follow IMWG guidelines

    "20" and "100" FLC ratio cut-points can be used with Sebia FLC assays, for an appropriate patient management and easier implementation in the laboratory.

  • 4 times lower retest rates

    vs other methods and lower manual dilutions needed.

  • Easily adapted and scalable

    to any type of ELISA Instrument for standardization and efficiency process.

  • Clinical performance

    96.8% concordance based on the IMWG Criteria for the Diagnosis of MM

Main characteristics

Test principle

Quantification of Kappa or Lambda Free Light Chains is performed with an Enzyme-Linked Immunosorbent Assay (ELISA) procedure utilizing specific antibodies anti-Kappa or anti-Lambda free light chains.

Sample type

Serum sample

Product details

Microplate with 96 wells in strip format.

  • FLC Kappa – P/N: 5102
  • FLC Lambda – P/N: 5103
  • FLC Control Level 1 – P/N: 5112
  • FLC Control Level 2 – P/N: 5113

Knowledge & Science

No content available.

FLC test can be performed on the following instruments

Tests related to FLC

This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.

Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.